Publications by authors named "Peter Mathen"

Claim this Profile
A
A review of diffuse hemispheric glioma, H3 G34-mutant disease development, DNA repair, microenvironment, and treatments on the horizon.
Cameron Crowell, Ziwen Zhu, Yingxiang Li, Maria L Varela, Quinn Ostrom, Peter Mathen

NPJ Precis Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic impact of PD-L1 and CD8 expression in anal cancer patients treated with chemoradiotherapy.
Angela My Chan, Gloria Roldan Urgoiti, Will Jiang, Sandra Lee, Elizabeth Kornaga, Peter Mathen

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma.
Charlotte Degorre, Philip Tofilon, Kevin Camphausen, Peter Mathen

Radiat Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reimagining external beam radiotherapy for glioblastoma: "old beam, new trick".
Peter Mathen, DeeDee K Smart

Neuro Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated glioma grading on conventional MRI images using deep convolutional neural networks.
Ying Zhuge, Holly Ning, Peter Mathen, Jason Y Cheng, Andra V Krauze

Med Phys· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiosensitizers in the temozolomide era for newly diagnosed glioblastoma.
Peter Mathen, Lindsay Rowe, Megan Mackey, DeeDee Smart, Philip Tofilon

Neurooncol Pract· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of altered body image in patients with primary brain tumors: an understudied population.
Lindsay Rowe, Elizabeth Vera, Alvina Acquaye, Sonja Crandon, Veeraj Shah, Peter Mathen

J Neurooncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The addition of Valproic acid to concurrent radiation therapy and temozolomide improves patient outcome: a Correlative analysis of RTOG 0525, SEER and a Phase II NCI trial.
A V Krauze, Mackey Megan, Cooley-Zgela Theresa, Mathen Peter, J H Shih

Cancer Stud Ther· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Serum Proteomic Signature Predicting Survival in Patients with Glioblastoma.
Mary Sproull, Peter Mathen, Charlotte Anne Miller, Megan Mackey, Teresa Cooley

J Biochem Anal Stud· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating biomarkers for high-grade glioma.
Hannah K Loo, Peter Mathen, Jennifer Lee, Kevin Camphausen

Biomark Med· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis